The startup develops ultrasound-guided needle insertion technology that provides real-time imaging and deflection of ultrasound waves for spinal injections and nerve blocks. This platform enhances the precision of needle placement, reducing the risk of complications during procedures.
Funding
$770K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Spinal injections and nerve blocks rely on precise needle placement, but current methods can be inaccurate, leading to complications and suboptimal patient outcomes. Clinicians often face challenges in visualizing the needle trajectory and target anatomy in real-time, increasing the risk of tissue damage and failed procedures.
Solution
Medulla Pro Technology offers a real-time ultrasound-guided device designed to enhance the accuracy and safety of needle insertion for spinal injections and nerve blocks. The device deflects ultrasound waves, providing clinicians with clear visualization of the needle's trajectory and the target site. This technology enables precise needle placement, reducing the risk of complications such as nerve damage or hematoma formation. The single-use design minimizes the risk of cross-contamination, while the plug-and-play compatibility with most ultrasound probes ensures easy integration into existing clinical workflows.
Target Audience
The primary target audience includes anesthesiologists, pain management specialists, and other clinicians performing spinal injections and nerve blocks.
Features
- Real-time ultrasound guidance for in-plane needle insertion
- Deflection of ultrasound waves for enhanced visualization of the needle tip and target anatomy
- Calibrated needle trajectory aligned with the ultrasound image
- Single-use design to eliminate cross-contamination risks
- Plug-and-play compatibility with most ultrasound probes